- Home
- ECOR
ECOR
electroCore Inc.
as 07-26-2024 4:00pm EST
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | ROCKAWAY |
| Market Cap: | 39.6M | IPO Year: | 2018 |
| Target Price: | $15.00 | AVG Volume (30 days): | 5.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.92 - $8.08 | Next Earning Date: | 08-07-2024 |
| Revenue: | $18,693,000 | Revenue Growth: | 97.33% |
| Revenue Growth (this year): | 54.76% | Revenue Growth (next year): | 40.61% |
Stock Insider Trading Activity of electroCore Inc. (ECOR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GANDOLFO JOHN P | ECOR | Director | Jun 13 '24 | Buy | $6.43 | 1,000 | $6,430.00 | 50,704 | SEC Form 4 |
| Goldberger Daniel S | ECOR | Chief Executive Officer | Jun 5 '24 | Buy | $6.43 | 38,505 | $247,587.15 | 249,565 | SEC Form 4 |
| POSNER BRIAN M | ECOR | Chief Financial Officer | Jan 12 '24 | Buy | $0.00 | 16,000 | $0.00 | 22,437 | SEC Form 4 |
Latest electroCore Inc. News
ECOR Breaking Stock News: Dive into ECOR Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
electroCore Announces the Commercial Launch of TAC-STIM™
Simply Wall St.
a month ago
electroCore, Inc.'s (NASDAQ:ECOR) Path To Profitability
GlobeNewswire
2 months ago
electroCore to Join Russell Microcap® Index
Argus Research
2 months ago
Daily – Vickers Top Buyers & Sellers for 06/07/2024
GuruFocus.com
2 months ago
Insider Buying: CEO Daniel Goldberger Acquires Shares of electroCore Inc (ECOR)
GlobeNewswire
2 months ago
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
GlobeNewswire
2 months ago
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
Zacks
2 months ago
Wall Street Analysts See a 251.77% Upside in electroCore (ECOR): Can the Stock Really Move This High?
Compare ECOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ECOR electroCore Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.